As of January 2025, Evogene has a market cap of $70.51M. This makes Evogene the world's 21536th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $37.58M | -8.94% |
2023 | $41.27M | 34.14% |
2022 | $30.77M | -58.42% |
2021 | $73.99M | -65.19% |
2020 | $212.55M | 193.76% |
2019 | $72.36M | -32.44% |
2018 | $107.10M | -31.15% |
2017 | $155.56M | -42.35% |
2016 | $269.82M | -37.02% |
2015 | $428.41M | -13.87% |
2014 | $497.38M | -46.98% |
2013 | $938.17M | 83.30% |
2012 | $511.83M | 24.02% |
2011 | $412.71M | -26.52% |
2010 | $561.66M | 53.38% |
2009 | $366.18M | 95.59% |
2008 | $187.22M | 63.58% |
2007 | $114.45M | - |